Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 48, 425-429, January 15, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Taguchi, O.
Right arrow Articles by Nishizuka, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Taguchi, O.
Right arrow Articles by Nishizuka, Y.

Rapid Induction of Ovarian Granulosa Cell Tumors by 7,12-Dimethylbenz(a)anthracene in Neonatally Estrogenized Mice1

Osamu Taguchi2, Sandra D. Michael and Yasuaki Nishizuka

Laboratory of Experimental Pathology, Aichi Cancer Center Research Institute, Chikusa-ku, Nagoya 464, Japan [O. T., Y. N.]; and Department of Biological Sciences, University Center at Binghamton, State University of New York, Binghamton, New York 13901 [S. D. M.]

Groups of female C3H/HeMs x 129/J F1 mice were given injections of either 20 µg of 17ß-estradiol or sesame oil (vehicle) for the first 5 days after birth. Half of each group was then given gastric intubations of 20 mg/kg of 7,12-dimethylbenz(a)anthracene (DMBA) at 70, 77, and 84 days of age. The other half of each group was given sesame oil. Thus, this design yielded four experimental groups: oil + oil; 17ß-estradiol + oil; oil + DMBA; and 17ß-estradiol + DMBA. They were sacrificed at approximately 144 days of age (Experiment 1) or the day of palpable ovarian tumor detection or 360 days of age (Experiment 2). In Experiment 1, the total number of oocytes (follicles) per ovary in mice of the 17ß-estradiol + oil group was maintained at the same level as mice of the oil + oil group. A significant reduction of oocytes, however, was observed in mice of the 17ß-estradiol + DMBA group in comparison with mice of the oil + DMBA group (P < 0.01), and neoplastic nodules of the granulosa cell type developed in the unilateral ovary in 10 of 17 mice of the 17ß-estradiol + DMBA group. No tumors were detected in the mice of the other groups. The plasma levels of both follicle-stimulating and luteinizing hormones as determined by radioimmunoassay were significantly higher (P < 0.01) in mice of the 17ß-estradiol + oil group than in mice of the oil + oil group. In Experiment 2, more ovarian tumors of the granulosa cell type were detected before 360 days of age in mice of the 17ß-estradiol + DMBA group (14 of 18) than in mice of the oil + DMBA group (5 of 15) (P < 0.05). No tumors developed in mice of the other two groups. These results strongly indicate that an abnormal endocrine milieu caused by neonatal treatment with estrogen may induce a high frequency of transformation of some ovarian tissues and rapid growth of the ovarian tumors after DMBA treatment.

1 This work was supported in part by a Grant-in-Aid for Scientific Research and Cancer Research from the Ministry of Education, Science, and Culture, Japan, and by NIH Grant CA-34344.

2 To whom requests for reprints should be addressed.

Received 12/10/86. Revised 9/30/87. Accepted 10/ 5/87.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
C. J. Nicol, M. Yoon, J. M. Ward, M. Yamashita, K. Fukamachi, J. M. Peters, and F. J. Gonzalez
PPAR{gamma} influences susceptibility to DMBA-induced mammary, ovarian and skin carcinogenesis
Carcinogenesis, September 1, 2004; 25(9): 1747 - 1755.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
C. C. Capen
Mechanisms of Hormone-Mediated Carcinogenesis of the Ovary
Toxicol Pathol, February 1, 2004; 32(2_suppl): 1 - 5.
[Abstract] [PDF]


Home page
Mol. Endocrinol.Home page
G. E. Owens, R. A. Keri, and J. H. Nilson
Ovulatory Surges of Human CG Prevent Hormone-Induced Granulosa Cell Tumor Formation Leading to the Identification of Tumor-Associated Changes in the Transcriptome
Mol. Endocrinol., June 1, 2002; 16(6): 1230 - 1242.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
R. Masson, O. Lefebvre, A. Noel, M. E. Fahime, M.-P. Chenard, C. Wendling, F. Kebers, M. LeMeur, A. Dierich, J.-M. Foidart, et al.
In Vivo Evidence That the Stromelysin-3 Metalloproteinase Contributes in a Paracrine Manner to Epithelial Cell Malignancy
J. Cell Biol., March 23, 1998; 140(6): 1535 - 1541.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
A. Amsterdam and N. Selvaraj
Control of Differentiation, Transformation, and Apoptosis in Granulosa Cells by Oncogenes, Oncoviruses, and Tumor Suppressor Genes
Endocr. Rev., August 1, 1997; 18(4): 435 - 461.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
T. J. Kotlar, R. H. Young, C. Albanese, W. F. Crowley Jr., R. E. Scully, and J. L. Jameson
A Mutation in the Follicle-Stimulating Hormone Receptor Occurs Frequently in Human Ovarian Sex Cord Tumors
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1020 - 1026.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1988 by the American Association for Cancer Research.